These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38232138)

  • 1. TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia.
    Marks JD; Ayuso VE; Carlomagno Y; Yue M; Todd TW; Hao Y; Li Z; McEachin ZT; Shantaraman A; Duong DM; Daughrity LM; Jansen-West K; Shao W; Calliari A; Bejarano JG; DeTure M; Rawlinson B; Casey MC; Lilley MT; Donahue MH; Jawahar VM; Boeve BF; Petersen RC; Knopman DS; Oskarsson B; Graff-Radford NR; Wszolek ZK; Dickson DW; Josephs KA; Qi YA; Seyfried NT; Ward ME; Zhang YJ; Prudencio M; Petrucelli L; Cook CN
    Sci Transl Med; 2024 Jan; 16(730):eadf9735. PubMed ID: 38232138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
    Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
    J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes.
    Busch JI; Unger TL; Jain N; Tyler Skrinak R; Charan RA; Chen-Plotkin AS
    Hum Mol Genet; 2016 Jul; 25(13):2681-2697. PubMed ID: 27126638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia.
    van Blitterswijk M; Mullen B; Nicholson AM; Bieniek KF; Heckman MG; Baker MC; DeJesus-Hernandez M; Finch NA; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
    Acta Neuropathol; 2014 Mar; 127(3):397-406. PubMed ID: 24385136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.
    Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM
    J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging.
    Perneel J; Neumann M; Heeman B; Cheung S; Van den Broeck M; Wynants S; Baker M; Vicente CT; Faura J; Rademakers R; Mackenzie IRA
    Acta Neuropathol; 2023 Mar; 145(3):285-302. PubMed ID: 36527486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel temporal-predominant neuro-astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD/ALS-TDP.
    Llibre-Guerra JJ; Lee SE; Suemoto CK; Ehrenberg AJ; Kovacs GG; Karydas A; Staffaroni A; Franca Resende EP; Kim EJ; Hwang JH; Ramos EM; Wojta KJ; Pasquini L; Pang SY; Spina S; Allen IE; Kramer J; Miller BL; Seeley WW; Grinberg LT
    Brain Pathol; 2021 Mar; 31(2):267-282. PubMed ID: 33314436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of a protective effect of the Tmem106b "protective SNP" in the Grn knockout mouse model for frontotemporal lobar degeneration.
    Cabron AS; Borgmeyer U; Richter J; Peisker H; Gutbrod K; Dörmann P; Capell A; Damme M
    Acta Neuropathol Commun; 2023 Jan; 11(1):21. PubMed ID: 36707901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TMEM106B locus and TDP-43 pathology in older persons without FTLD.
    Yu L; De Jager PL; Yang J; Trojanowski JQ; Bennett DA; Schneider JA
    Neurology; 2015 Mar; 84(9):927-34. PubMed ID: 25653292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.
    Gallagher MD; Suh E; Grossman M; Elman L; McCluskey L; Van Swieten JC; Al-Sarraj S; Neumann M; Gelpi E; Ghetti B; Rohrer JD; Halliday G; Van Broeckhoven C; Seilhean D; Shaw PJ; Frosch MP; Alafuzoff I; Antonell A; Bogdanovic N; Brooks W; Cairns NJ; Cooper-Knock J; Cotman C; Cras P; Cruts M; De Deyn PP; DeCarli C; Dobson-Stone C; Engelborghs S; Fox N; Galasko D; Gearing M; Gijselinck I; Grafman J; Hartikainen P; Hatanpaa KJ; Highley JR; Hodges J; Hulette C; Ince PG; Jin LW; Kirby J; Kofler J; Kril J; Kwok JB; Levey A; Lieberman A; Llado A; Martin JJ; Masliah E; McDermott CJ; McKee A; McLean C; Mead S; Miller CA; Miller J; Munoz DG; Murrell J; Paulson H; Piguet O; Rossor M; Sanchez-Valle R; Sano M; Schneider J; Silbert LC; Spina S; van der Zee J; Van Langenhove T; Warren J; Wharton SB; White CL; Woltjer RL; Trojanowski JQ; Lee VM; Van Deerlin V; Chen-Plotkin AS
    Acta Neuropathol; 2014 Mar; 127(3):407-18. PubMed ID: 24442578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis.
    Vass R; Ashbridge E; Geser F; Hu WT; Grossman M; Clay-Falcone D; Elman L; McCluskey L; Lee VM; Van Deerlin VM; Trojanowski JQ; Chen-Plotkin AS
    Acta Neuropathol; 2011 Mar; 121(3):373-80. PubMed ID: 21104415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.
    Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS
    Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.
    Van Deerlin VM; Sleiman PM; Martinez-Lage M; Chen-Plotkin A; Wang LS; Graff-Radford NR; Dickson DW; Rademakers R; Boeve BF; Grossman M; Arnold SE; Mann DM; Pickering-Brown SM; Seelaar H; Heutink P; van Swieten JC; Murrell JR; Ghetti B; Spina S; Grafman J; Hodges J; Spillantini MG; Gilman S; Lieberman AP; Kaye JA; Woltjer RL; Bigio EH; Mesulam M; Al-Sarraj S; Troakes C; Rosenberg RN; White CL; Ferrer I; Lladó A; Neumann M; Kretzschmar HA; Hulette CM; Welsh-Bohmer KA; Miller BL; Alzualde A; Lopez de Munain A; McKee AC; Gearing M; Levey AI; Lah JJ; Hardy J; Rohrer JD; Lashley T; Mackenzie IR; Feldman HH; Hamilton RL; Dekosky ST; van der Zee J; Kumar-Singh S; Van Broeckhoven C; Mayeux R; Vonsattel JP; Troncoso JC; Kril JJ; Kwok JB; Halliday GM; Bird TD; Ince PG; Shaw PJ; Cairns NJ; Morris JC; McLean CA; DeCarli C; Ellis WG; Freeman SH; Frosch MP; Growdon JH; Perl DP; Sano M; Bennett DA; Schneider JA; Beach TG; Reiman EM; Woodruff BK; Cummings J; Vinters HV; Miller CA; Chui HC; Alafuzoff I; Hartikainen P; Seilhean D; Galasko D; Masliah E; Cotman CW; Tuñón MT; Martínez MC; Munoz DG; Carroll SL; Marson D; Riederer PF; Bogdanovic N; Schellenberg GD; Hakonarson H; Trojanowski JQ; Lee VM
    Nat Genet; 2010 Mar; 42(3):234-9. PubMed ID: 20154673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
    Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
    Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What we know about TMEM106B in neurodegeneration.
    Nicholson AM; Rademakers R
    Acta Neuropathol; 2016 Nov; 132(5):639-651. PubMed ID: 27543298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency.
    Zhou X; Sun L; Brady OA; Murphy KA; Hu F
    Acta Neuropathol Commun; 2017 Jan; 5(1):9. PubMed ID: 28126008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMEM106B Fibrils from FTLD Patients and Healthy Controls.
    Greenwood JD; Powell WC; Walczak MA
    ACS Chem Neurosci; 2023 Aug; 14(16):2827-2829. PubMed ID: 37530644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Lysosomal Trafficking Transmembrane Protein 106B Is Linked to Cell Death.
    Suzuki H; Matsuoka M
    J Biol Chem; 2016 Oct; 291(41):21448-21460. PubMed ID: 27563066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes.
    T Vicente C; Perneel J; Wynants S; Heeman B; Van den Broeck M; Baker M; Cheung S; Faura J; Mackenzie IRA; Rademakers R
    Brain; 2023 Oct; 146(10):4055-4064. PubMed ID: 37100087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43.
    Jiang YX; Cao Q; Sawaya MR; Abskharon R; Ge P; DeTure M; Dickson DW; Fu JY; Ogorzalek Loo RR; Loo JA; Eisenberg DS
    Nature; 2022 May; 605(7909):304-309. PubMed ID: 35344984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.